Business Wire

CT-XEROX

Share
Xerox Reveals Suite of Production Print Innovations to Address Industry Demand

Xerox (NYSE: XRX) announced a suite of production print innovations including new presses, technology enhancements for existing printers as well as artificial intelligence and automation features that aid speed and productivity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118006025/en/

At a virtual event attended by partners and clients around the world, Xerox unveiled the following innovations:

  • A Color Accelerator module for Baltoro, expanding inkjet applications and adding ink-saving automation
  • Addition of fluorescent pink to the Iridesse Production Press, enhancing its metallics, white and clear color palette
  • Three new printers capable of higher volumes, more media and extended color options in the VersaLink and Versant family
  • Two Xerox Nuvera print speed upgrades that best competition
  • AI-enabled media manager software that enables high-quality images with minimal set-up and staff time
  • Automated workflow updates to seamlessly print embellishments with FreeFlow Core 6.0

As the leader in the production color market, Xerox is committed to helping customers expand their business, enhance productivity with new technology and protect their existing investments with new tools and features.

Digital print enhancements increase profitability, delivering higher margins and allowing print customers to expand into new areas. According to Keypoint Intelligence, digital print enhancement is expected to generate $25 billion a year and can increase a printers’ profit by 50 to 400 percent. By making it easier, customizable and faster to produce these pages, Xerox technology provides multiple entry options for customers to expand their business and increase profit.

“Print enhancement is the fastest-growing segment in print and Xerox offers the broadest set of solutions to help clients expand their business here,” said Tracey Koziol, senior vice president of Global Offerings, Xerox. “The new technology and features we are launching expand the capabilities and profit potential of existing devices while introducing new presses that respond to demand for higher volume and extended media and color palettes. There’s a reason Xerox remains top in the production print market.”

Xerox Color Accelerator for Baltoro
The Xerox Baltoro™ High Fusion Inkjet Press platform, No. 1 in the B3 cut-sheet inkjet market, now has a field-upgradable module that expands its range. The Xerox Color Accelerator for Xerox Baltoro HF Inkjet Press enables increased print quality, expanded media options and automation to make inkjet printing viable for lucrative applications such as direct mail, postcards and catalogs. With intelligent automation, Baltoro uses 50% less ink than competitor presses to purge inkjet heads, increasing uptime and productivity while delivering consistent, reliable quality.

Introduced last year, Baltoro is redefining the inkjet market. At a fraction of the size, weight and power consumption of competitor presses, Baltoro offers a lower total cost of ownership (TCO) while being the only scalable, customizable platform in its class.

Fluorescent Pink for Iridesse
Xerox has the broadest color capability and Beyond CMYK offerings across any portfolio. No one offers the range of colors, embellishments, mixed metallics, extended gamut, media options and single-pass digital enhancement technology as Xerox.

The Xerox Iridesse® Production Press is adding fluorescent pink specialty dry ink option to its existing Beyond CMYK palette of gold, silver, white and clear. These embellishments allow print providers to differentiate and offer their clients eye-popping designs and enhancements.

New VersaLink Graphic Arts Printer
The newest addition to our VersaLink family is the Xerox VersaLink® C8000W , the most affordable entry point into the embellishment market. Using white toner as a base on dark and colored stocks, its cyan, magenta and yellow toners make images pop for applications such as menus, envelopes, window clings, decals and labels. A small footprint device, the C8000W offers clarity and quality that stands out over the typical four-color print.

Two New Versants
Xerox is expanding its Versant family of presses with two new machines that support wider media options and add automation features that reduce staffing needs and set-up time.

The Xerox Versant® 280 Press , a mid-production press, provides added value with thicker stock media options (400 GSM) for applications such as business cards. With the All Stocks at Rated Speed (ASRS) option, the Versant 280 is faster than any competitor in printing heavy stocks. Customers can print a million specialty colors using an Adaptive CMYK+ kit that leverages white, gold, silver, clear and fluorescents, unique to Xerox in this class of products.

The Xerox Versant 4100 Press , handles higher volumes and heavier production loads than the Versant 280, bringing more jobs in-house by reducing set-up time and printing on more media types than any competitor press. The 4100 also handles thicker paper stocks, up to 400 GSM. Automated stock management saves time and reduces human error.

Faster Xerox Nuveras
The Xerox Nuvera® family is built for high production environments with our customers making more than 35 billion prints last year. The Xerox Nuvera 157 MX Production System and Xerox Nuvera MX Perfecting Production System monochrome production presses have upgraded the magnetic ink character recognition (MICR) print speeds to exceed any competitive press. MICR, the line of numbers that allows certain computers to read and process information, is key for processing bank, payroll and government checks with tested and trusted Xerox Nuvera security.

Technology-Driven Efficiencies
AI-enabled media manager software. PredictPrint Media Manager Software is included with the new Versant 4100 and can be added to Iridesse. By using artificial intelligence, the software automatically identifies the media being used and provides the correct press settings. Users simply scan a barcode, place the paper in a tray, and use the set-up wizard to walk through optimizing the system for that application.

FreeFlow® Core 6.0 automates the process of preparing a file to print and now includes the application of Beyond CMYK enhancements. FreeFlow Core uses pre-built workflows to seamlessly apply embellishments such as gold, silver, white, clear and fluorescents without changing the source file.

“These new products and features represent the sweet spot of technology, where end-to-end solutions support our customers need to differentiate and expand their businesses in any economic environment,” said Marybeth Gilbert, vice president and general manager, Production Business, Xerox. “Our customers know they can count on Xerox innovation in response to their business needs.”

Availability:

  • Xerox Color Accelerator for Xerox Baltoro HF Inkjet Press - Current Baltoro customers will be able to order Color Accelerator beginning in 2021. New Baltoro customers will be able to place orders for Color Accelerator starting December 15 with installs expected to begin in Q1 2021.
  • The VersaLink C8000W is available immediately worldwide.
  • The Xerox Nuvera 157 MX Production System and Xerox Nuvera 314 MX Perfecting Production System - order taking and availability December 1, 2020.
  • The Xerox Versant 280 is available now based upon channel and geography.
  • The Xerox Versant 4100 with PredictPrint Media Manager Software is available now based upon channel and geography.
  • Iridesse pink specialty dry ink option and the PredictPrint Media Manager Software option are available for order taking December 1, 2020 and availability beginning March 1, 2021.
  • The XLS Automatic Feeding Kit option for Iridesse is available immediately worldwide.

About Xerox
Xerox Holdings Corporation (NYSE: XRX) makes every day work better.
We are a workplace technology company building and integrating software and hardware for enterprises large and small. As customers seek to manage information across digital and physical platforms, Xerox delivers a seamless, secure and sustainable experience. Whether inventing the copier, Ethernet, the laser printer or more, Xerox has long defined the modern work experience. Learn how that innovation continues at xerox.com .

Note: To receive RSS news feeds, visit https://www.news.xerox.com . For open commentary, industry perspectives and views, visit http://twitter.com/xerox , http://www.facebook.com/XeroxCorp , https://www.instagram.com/xerox/ , http://www.linkedin.com/company/xerox , http://www.youtube.com/XeroxCorp .

Xerox® , Baltoro™, FreeFlow® , Iridesse® , VersaLink® , Versant® and Xerox Nuvera® are trademarks of Xerox in the United States and/or other countries.

Link:

ClickThru

Social Media:

https://www.facebook.com/XeroxCorp/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release

Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye